Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
ICU
ICU
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ICU News
SeaStar Medical CEO to Join Investor Forum
1d ago
Newsfilter
Life Sciences Virtual Investor Forum Agenda Announced
1m ago
Globenewswire
SeaStar Medical CEO to Participate in Investor Forum
1d ago
Globenewswire
SeaStar Completes Patient Enrollment in SAVE Registry for QUELIMMUNE Therapy
5d ago
Newsfilter
SEASTAR MEDICAL CONFIRMS FULFILLMENT OF FDA ENROLLMENT CRITERIA FOR SAVE SURVEILLANCE REGISTRY ASSESSING QUELIMMUNE SAFETY IN PEDIATRIC AKI
5d ago
moomoo
SeaStar Medical Releases Survival Data for QUELIMMUNE Therapy
Feb 09 2026
Newsfilter
SeaStar Medical Expands QUELIMMUNE Adoption, Anticipates $2 Million Revenue in 2026
Jan 07 2026
Globenewswire
SeaStar Medical Announces 1-for-10 Reverse Split, Shares Drop 9.5%
Dec 24 2025
Benzinga
Multi Ways Holdings Reports 87.65% Revenue Growth to $26.44 Million in H1 2025
Dec 24 2025
Benzinga
SeaStar Medical Executes 1-for-10 Reverse Stock Split to Meet Nasdaq Compliance
Dec 23 2025
Globenewswire
What’s Happening with SeaStar Medical's Stock Today?
Dec 19 2025
Benzinga
Oracle Shares Rise Over 5%; Check Out 20 Stocks Making Moves in Premarket Trading
Dec 19 2025
Benzinga
SeaStar Medical Reduces FDA Surveillance Requirement to 50 Patients
Dec 02 2025
Newsfilter
Biotech and Healthcare Stocks Top After-Hours Gainers: ICU, CGTX, MESO, VRCA, AHCO
Nov 26 2025
NASDAQ.COM
SeaStar Medical Scheduled to Present at NobleCon21 Investor Conference on December 3, 2025
Nov 24 2025
NASDAQ.COM
SeaStar Medical to Showcase at NobleCon21 Investor Conference
Nov 20 2025
Newsfilter
Show More News
